Jacobs Levy Equity Management Inc. Purchases 477,634 Shares of Oscar Health, Inc. (NYSE:OSCR)

Jacobs Levy Equity Management Inc. grew its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 37.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,741,306 shares of the company's stock after buying an additional 477,634 shares during the period. Jacobs Levy Equity Management Inc. owned approximately 0.70% of Oscar Health worth $23,403,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Tower Research Capital LLC TRC increased its position in Oscar Health by 171.4% during the 4th quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company's stock worth $89,000 after buying an additional 4,185 shares during the period. KBC Group NV increased its position in Oscar Health by 56.1% during the 4th quarter. KBC Group NV now owns 7,107 shares of the company's stock worth $96,000 after buying an additional 2,555 shares during the period. Alberta Investment Management Corp bought a new position in Oscar Health during the 4th quarter worth $138,000. Virtu Financial LLC bought a new position in Oscar Health during the 4th quarter worth $140,000. Finally, Potentia Wealth bought a new position in Oscar Health during the 4th quarter worth $141,000. Institutional investors own 75.70% of the company's stock.

Insider Buying and Selling

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the transaction, the director now owns 64,512 shares in the company, valued at $1,059,932.16. The trade was a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 24.39% of the stock is owned by company insiders.

Oscar Health Price Performance

Shares of NYSE OSCR traded up $0.96 during mid-day trading on Friday, reaching $17.52. The company had a trading volume of 10,504,285 shares, compared to its average volume of 4,198,809. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.79. The firm has a market cap of $4.39 billion, a price-to-earnings ratio of -875.31 and a beta of 1.75. The business's 50-day simple moving average is $13.46 and its 200 day simple moving average is $14.65.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, topping analysts' consensus estimates of $0.83 by $0.09. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The company had revenue of $3 billion for the quarter, compared to analysts' expectations of $2.87 billion. During the same quarter last year, the business earned $0.62 earnings per share. Oscar Health's revenue was up 42.2% on a year-over-year basis. On average, research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Wells Fargo & Company cut Oscar Health from an "overweight" rating to an "equal weight" rating and lowered their price objective for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, Oscar Health presently has a consensus rating of "Hold" and an average price target of $20.08.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.